These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 22895980)

  • 1. Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community.
    Sheikh A; Simons FE; Barbour V; Worth A
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD008935. PubMed ID: 22895980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock.
    Sheikh A; Shehata YA; Brown SG; Simons FE
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD006312. PubMed ID: 18843712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenaline for the treatment of anaphylaxis: cochrane systematic review.
    Sheikh A; Shehata YA; Brown SG; Simons FE
    Allergy; 2009 Feb; 64(2):204-12. PubMed ID: 19178399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What are the 'ideal' features of an adrenaline (epinephrine) auto-injector in the treatment of anaphylaxis?
    Frew AJ
    Allergy; 2011 Jan; 66(1):15-24. PubMed ID: 20716315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids for the treatment of anaphylaxis.
    Choo KJ; Simons FE; Sheikh A
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD007596. PubMed ID: 22513951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoids for the treatment of anaphylaxis.
    Choo KJ; Simons FE; Sheikh A
    Cochrane Database Syst Rev; 2010 Mar; (3):CD007596. PubMed ID: 20238355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epinephrine Auto-Injector Versus Drawn Up Epinephrine for Anaphylaxis Management: A Scoping Review.
    Chime NO; Riese VG; Scherzer DJ; Perretta JS; McNamara L; Rosen MA; Hunt EA;
    Pediatr Crit Care Med; 2017 Aug; 18(8):764-769. PubMed ID: 28492400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epinephrine and its use in anaphylaxis: current issues.
    Simons KJ; Simons FE
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):354-61. PubMed ID: 20543673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epinephrine auto-injectors: first-aid treatment still out of reach for many at risk of anaphylaxis in the community.
    Simons FE;
    Ann Allergy Asthma Immunol; 2009 May; 102(5):403-9. PubMed ID: 19492662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epinephrine auto-injector pandemic.
    Campbell RL; Manivannan V; Hartz MF; Sadosty AT
    Pediatr Emerg Care; 2012 Sep; 28(9):938-42. PubMed ID: 22940899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylaxis treatment: current barriers to adrenaline auto-injector use.
    Song TT; Worm M; Lieberman P
    Allergy; 2014 Aug; 69(8):983-91. PubMed ID: 24835773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids for the treatment of anaphylaxis.
    Choo KJ; Simons FE; Sheikh A
    Evid Based Child Health; 2013 Jul; 8(4):1276-94. PubMed ID: 23877942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids for the treatment of anaphylaxis: Cochrane systematic review.
    Choo KJ; Simons E; Sheikh A
    Allergy; 2010 Oct; 65(10):1205-11. PubMed ID: 20584003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voluntarily reported unintentional injections from epinephrine auto-injectors.
    Simons FE; Edwards ES; Read EJ; Clark S; Liebelt EL
    J Allergy Clin Immunol; 2010 Feb; 125(2):419-423.e4. PubMed ID: 20159254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and cost-effectiveness analysis of specialist services and adrenaline auto-injectors in anaphylaxis.
    Armstrong N; Wolff R; van Mastrigt G; Martinez N; Hernandez AV; Misso K; Kleijnen J
    Health Technol Assess; 2013 Apr; 17(17):1-117, v-vi. PubMed ID: 23618619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylaxis management: the essential role of adrenaline (epinephrine) auto-injectors. Should PHARMAC fund them in New Zealand?
    Fitzharris P; Empson M; Ameratunga R; Sinclair J; Crump V; Steele R; Broom B
    N Z Med J; 2006 May; 119(1233):U1965. PubMed ID: 16680178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When every second counts: ampoule versus adrenaline auto-injector administration for life-threatening allergy.
    McDonald EM; Cooper E
    N Z Med J; 2019 Nov; 132(1505):79-82. PubMed ID: 31697666
    [No Abstract]   [Full Text] [Related]  

  • 18. How far from correct is the use of adrenaline auto-injectors? A survey in Italian patients.
    Ridolo E; Montagni M; Bonzano L; Savi E; Peveri S; Costantino MT; Crivellaro M; Manzotti G; Lombardi C; Caminati M; Incorvaia C; Senna G
    Intern Emerg Med; 2015 Dec; 10(8):937-41. PubMed ID: 25990486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic evidence of adrenaline administered via auto-injector for anaphylactic reactions: A review of literature.
    Moss J; Jani Y; Edwards B; Tomlin S; Rashed AN
    Br J Clin Pharmacol; 2021 Mar; 87(3):816-824. PubMed ID: 32559814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epinephrine auto-injector use in adolescents at risk of anaphylaxis: a qualitative study in Scotland, UK.
    Gallagher M; Worth A; Cunningham-Burley S; Sheikh A
    Clin Exp Allergy; 2011 Jun; 41(6):869-77. PubMed ID: 21481022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.